iPSC-derived Retinal Pigment Epithelial Cells in Research and Clinical Applications

 width=In this webinar, Dr. Kapil Bharti discussed the use of induced pluripotent stem (iPS) cell technology to develop in vitro disease models to study patient-specific disease processes, to set up high throughput drug screens, and to develop cell-based therapy for retinal degenerative disease.

Topics covered:

  • Characterization of iPSC-derived retinal pigment epithelium (RPE)
  • iPSC-derived RPE for ocular disease modeling
  • iPSC-derived RPE in clinical applications

For access to the video recording of this webinar, please register here.


Start: 2018-01-12

End: 2018-01-12

Website: https://register.gotowebinar.com/register/7194341362404811011

Organizer: Cellular Dynamics International


Event Details:

Event Date: 2018-01-12 To 2018-01-12

Organiser: Cellular Dynamics International

Website: https://register.gotowebinar.com/register/7194341362404811011